Your browser doesn't support javascript.
loading
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI).
Banerjee, Susana; Stewart, James; Porta, Nuria; Toms, Christy; Leary, Alexandra; Lheureux, Stephanie; Khalique, Saira; Tai, Jeremy; Attygalle, Ayoma; Vroobel, Katherine; Lord, Christopher J; Natrajan, Rachael; Bliss, Judith.
Afiliación
  • Banerjee S; Gynaecology Unit, Royal Marsden NHS Foundation Trust, London, UK susana.banerjee@rmh.nhs.uk.
  • Stewart J; Division of Clinical Studies, The Institute of Cancer Research, London, UK.
  • Porta N; Gynaecology Unit, Royal Marsden NHS Foundation Trust, London, UK.
  • Toms C; The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK.
  • Leary A; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Lheureux S; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Khalique S; Oncology Department, Institut Gustave-Roussy, Villejuif, Île-de-France, France.
  • Tai J; Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Attygalle A; Gynaecology Unit, Royal Marsden NHS Foundation Trust, London, UK.
  • Vroobel K; The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK.
  • Lord CJ; Gynaecology Unit, Royal Marsden NHS Foundation Trust, London, UK.
  • Natrajan R; Gynaecology Unit, Royal Marsden NHS Foundation Trust, London, UK.
  • Bliss J; Gynaecology Unit, Royal Marsden NHS Foundation Trust, London, UK.
Int J Gynecol Cancer ; 31(11): 1471-1475, 2021 11.
Article en En | MEDLINE | ID: mdl-34518240
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Ftalazinas / Piperazinas / Pirimidinas / Sulfonamidas / Morfolinas / Inhibidores de Proteínas Quinasas / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Indoles Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Ftalazinas / Piperazinas / Pirimidinas / Sulfonamidas / Morfolinas / Inhibidores de Proteínas Quinasas / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Indoles Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Año: 2021 Tipo del documento: Article